These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17981909)

  • 1. A quantum mechanic/molecular mechanic study of the wild-type and N155S mutant HIV-1 integrase complexed with diketo acid.
    Alves CN; Martí S; Castillo R; Andrés J; Moliner V; Tuñón I; Silla E
    Biophys J; 2008 Apr; 94(7):2443-51. PubMed ID: 17981909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantum mechanics/molecular mechanics study of the protein-ligand interaction for inhibitors of HIV-1 integrase.
    Alves CN; Martí S; Castillo R; Andrés J; Moliner V; Tuñón I; Silla E
    Chemistry; 2007; 13(27):7715-24. PubMed ID: 17570717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid quantum mechanical/molecular mechanical molecular dynamics simulations of HIV-1 integrase/inhibitor complexes.
    Nunthaboot N; Pianwanit S; Parasuk V; Ebalunode JO; Briggs JM; Kokpol S
    Biophys J; 2007 Nov; 93(10):3613-26. PubMed ID: 17693479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calculation of binding energy using BLYP/MM for the HIV-1 integrase complexed with the S-1360 and two analogues.
    Alves CN; Martí S; Castillo R; Andrés J; Moliner V; Tuñón I; Silla E
    Bioorg Med Chem; 2007 Jun; 15(11):3818-24. PubMed ID: 17420131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal-dependent inhibition of HIV-1 integrase by beta-diketo acids and resistance of the soluble double-mutant (F185K/C280S).
    Marchand C; Johnson AA; Karki RG; Pais GC; Zhang X; Cowansage K; Patel TA; Nicklaus MC; Burke TR; Pommier Y
    Mol Pharmacol; 2003 Sep; 64(3):600-9. PubMed ID: 12920196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: mechanism for inhibition and drug resistance.
    Barreca ML; Lee KW; Chimirri A; Briggs JM
    Biophys J; 2003 Mar; 84(3):1450-63. PubMed ID: 12609852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into saquinavir resistance in the G48V HIV-1 protease: quantum calculations and molecular dynamic simulations.
    Wittayanarakul K; Aruksakunwong O; Saen-oon S; Chantratita W; Parasuk V; Sompornpisut P; Hannongbua S
    Biophys J; 2005 Feb; 88(2):867-79. PubMed ID: 15542562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the interactions between diketo-acid inhibitors and prototype foamy virus integrase-DNA complex via molecular docking and comparative molecular dynamics simulation methods.
    Hu JP; He HQ; Tang DY; Sun GF; Zhang YQ; Fan J; Chang S
    J Biomol Struct Dyn; 2013; 31(7):734-47. PubMed ID: 22913375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding modes of diketo-acid inhibitors of HIV-1 integrase: a comparative molecular dynamics simulation study.
    Huang M; Grant GH; Richards WG
    J Mol Graph Model; 2011 Jun; 29(7):956-64. PubMed ID: 21531158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors.
    Chen X; Tsiang M; Yu F; Hung M; Jones GS; Zeynalzadegan A; Qi X; Jin H; Kim CU; Swaminathan S; Chen JM
    J Mol Biol; 2008 Jul; 380(3):504-19. PubMed ID: 18565342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative molecular dynamics simulations of HIV-1 integrase and the T66I/M154I mutant: binding modes and drug resistance to a diketo acid inhibitor.
    Brigo A; Lee KW; Fogolari F; Mustata GI; Briggs JM
    Proteins; 2005 Jun; 59(4):723-41. PubMed ID: 15815973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel HIV integrase inhibitors with anti-HIV activity: insights into integrase inhibition from docking studies.
    Cox AG; Nair V
    Antivir Chem Chemother; 2006; 17(6):343-53. PubMed ID: 17249248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H.
    Corona A; di Leva FS; Rigogliuso G; Pescatori L; Madia VN; Subra F; Delelis O; Esposito F; Cadeddu M; Costi R; Cosconati S; Novellino E; di Santo R; Tramontano E
    Antiviral Res; 2016 Oct; 134():236-243. PubMed ID: 27659398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale conformational dynamics of the HIV-1 integrase core domain and its catalytic loop mutants.
    Lee MC; Deng J; Briggs JM; Duan Y
    Biophys J; 2005 May; 88(5):3133-46. PubMed ID: 15731379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the binding mode and resistance profile for a dual-target pyrrolyl diketo acid scaffold against HIV-1 integrase and reverse-transcriptase-associated ribonuclease H.
    Yang F; Zheng G; Fu T; Li X; Tu G; Li YH; Yao X; Xue W; Zhu F
    Phys Chem Chem Phys; 2018 Sep; 20(37):23873-23884. PubMed ID: 29947629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of human immunodeficiency virus type 1 concerted integration related to strand transfer inhibition and drug resistance.
    Zahm JA; Bera S; Pandey KK; Vora A; Stillmock K; Hazuda D; Grandgenett DP
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3358-68. PubMed ID: 18591263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the molecular mechanism of cross-resistance to HIV-1 integrase strand transfer inhibitors by molecular dynamics simulation and residue interaction network analysis.
    Xue W; Jin X; Ning L; Wang M; Liu H; Yao X
    J Chem Inf Model; 2013 Jan; 53(1):210-22. PubMed ID: 23231029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental/theoretical electrostatic properties of a styrylquinoline-type HIV-1 integrase inhibitor and its progenitors.
    Firley D; Courcot B; Gillet JM; Fraisse B; Zouhiri F; Desmaële D; d'Angelo J; Ghermani NE
    J Phys Chem B; 2006 Jan; 110(1):537-47. PubMed ID: 16471566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based virtual screening toward the discovery of novel inhibitors for impeding the protein-protein interaction between HIV-1 integrase and human lens epithelium-derived growth factor (LEDGF/p75).
    Panwar U; Singh SK
    J Biomol Struct Dyn; 2018 Sep; 36(12):3199-3217. PubMed ID: 28948865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituent-modulated affinities of halobenzene derivatives to the HIV-1 integrase recognition site. Analyses of the interaction energies by parallel quantum chemical and polarizable molecular mechanics.
    El Hage K; Piquemal JP; Hobaika Z; Maroun RG; Gresh N
    J Phys Chem A; 2014 Oct; 118(41):9772-82. PubMed ID: 25230384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.